the organization cited a lack of clinical and non-clinical safety information, human data, and evidence of efficacy as reasons why they recommend the peptides remain off the 503A Bulks list
doi: 10.1046/j.1471-4159.1999.0720422.x 237 RuckerR
Ipamorelin and CJC-1295 are peptides used to potentially enhance growth hormone release, leading to benefits like muscle growth, fat loss, improved recovery, and overall well-being
RELATED: How Nicotinamide Riboside (NR) Is Linked to Increased NAD Levels and Healthy Aging Manufacturers declared adequate supply, and the agency sent cease-and-desist notices: stop making these compounds, you have 90 days
Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Marchal M, et al